Business Development Clinical Informatics Manufacturing Market Access Medical Devices and Diagnostics Pre-Clinical (Discovery and Development) Regulatory/Legal Pharma Logistics

Filter Categories

Business Development Clinical Informatics Manufacturing Market Access Medical Devices and Diagnostics Pre-Clinical (Discovery and Development) Regulatory/Legal Pharma Logistics

Troubleshooting Biomarker Development Strategies

Add bookmark

Gabriele Dallmann
06/09/2011

Troubleshooting Biomarker Development Strategies

Add bookmark

By: Gabriele Dallmann, Gabriele Dallmann 06/09/2011

In this Pharma IQ interview Kristof Vercruysse, Director Clinical Operations at Ablynx, speaks to Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, about innovation in phase I clinical development and optimisation of biomarker development strategies. Vercruysse discusses biomarker development strategies, which are of great importance for every clinical trial – he identifies the critical success factors, the optimum time to start biomarker development and how it is decided which clini...

Tags: Kristof Vercruysse Ablynx Gabriele Dallmann Pharmatching biomarkers Biomarker biomarker development phase one clinical Clinical Trials phase one clinical trials phase 1 phase I clinical development

Upcoming Events

Pharmaceutical Launch Excellence Summit

2 - 3 December, 2025

UK

Register Now View Agenda View Event

Pharmaceutical Launch Excellence Summit

SmartLab Exchange Europe

23 - 24 February 2026

Amsterdam

Register Now View Agenda View Event

SmartLab Exchange Europe

Pharma Contract Manufacturing

23 - 25 March 2026

Germany

Register Now View Agenda View Event

Pharma Contract Manufacturing

SmartLab Exchange USA

April 21 - 22, 2026

Philadelphia, USA

Register Now View Agenda View Event

SmartLab Exchange USA

Follow Us

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

A post-pandemic 3D view of the patient and supply journey

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

Recommended